Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

  • Lymphoma Program

    Dana-Farber/Brigham and Women's Cancer Care

    The Lymphoma Program is part of the Hematologic Oncology Treatment Center. Our specialists are experienced in providing treatment for the many varieties of lymphoid malignancies, including Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), B-cell neoplasms, and T-cell neoplasms.

    About the Program

    The Lymphoma Program provides care for the many varieties of lymphoid malignancies, including Non-Hodgkin lymphoma, Hodgkin lymphoma, B-cell neoplasms, and T-cell neoplasms. Your care will involve the best treatments currently available, combined with new therapies based on research in our laboratories and elsewhere in the field of lymphoma treatment.

    Our Treatment Approach

    Our program offers patients access to a multidisciplinary team of lymphoma experts with extensive experience caring for patients with lymphoid malignancies. This experience is particularly important because of the complexity of this type of cancer: There are more than 20 tumor types, each with a unique natural history and each requiring a different approach to treatment.

    We provide comprehensive services to patients with lymphoma, including:


    The Treatment Team

    The Lymphoma Program treatment team includes physicians and clinicians with extensive experience caring for patients with lymphoid tumors, as well as conducting research of lymphomas.

    Lymphoma Program Leadership

    Margaret Shipp, MD, Chief, Division of Hematologic Neoplasia and Program Director, Lymphoma; Director, Lymphoma Research Center
    Philippe Armand, MD, PhD, Director, Lymphoma Clinical Research
    Eric Jacobsen, MD, Clinical Director

    Lymphoma Physicians

    Jennifer R. Brown, MD, PhD
    George Canellos, MD
    Matthew S. Davids, MD, MMSc
    David C. Fisher, MD
    David Frank, MD, PhD
    Arnold Freedman, MD
    Eric Jacobsen, MD
    Caron A. Jacobson, MD
    Austin I. Kim, MD
    Ann LaCasce, MD
    Lee M. Nadler, MD
    Sam Ng, MD
    Oreofe O. Odejide, MD

    Radiation Oncology

    Andrea K. Ng, MD, MPH

    Lymphoma Nursing and Physician Assistant Team

    Kimberly Coleman, RN
    Karen Francoeur, RN
    Jeffrey Hellman, PA-C
    Margaret Hill, RN
    Kathleen McDermott, RN
    Nadia Murray, NP
    Victoria Patterson, RN
    Katherine Stephans, NP
    Susan Twohig, RN
    Barbara Virchick, NP

    We work closely with our transplant service team when patients require bone marrow/stem cell transplantation.


    Clinical Research

    The goal of the program's clinical research effort is to make the treatment of lymphoid malignancies more effective and specific, while also less toxic. Toward that goal, the program makes promising new therapies available to patients with a variety of lymphoid malignancies, in a carefully monitored setting, through clinical trials.

    Current research focuses on targeting tumors with drugs directed against specific molecular targets in lymphoid malignancies, or with antibodies reactive against tumor cell surface proteins, alone or linked to radionucleotides. Another target of therapy is the tumor's "microenvironment" using inhibitors of angiogenesis (new blood vessel development) and stimulators of the immune response. Our team is also leading several clinical trials of CAR T-cell therapy for lymphoma.

    Many members of the clinical research team also have active programs of laboratory-based investigation in lymphoid malignancies. Researchers work closely with other scientists within Harvard Medical School-affiliated institutions.


    Contact Us

    New Patients

    Lymphoma: 617-632-6246 or 617-632-5138, or use this online form to make an appointment.

    You may schedule your first appointment for as soon as the next day. After scheduling, one of our nurses will call you to answer your questions and help you prepare for the appointment.

    Current Patients

    Contact your doctor directly, or for general inquiries, call the Hematologic Malignancies program at 617-632-6140.



    Mailing address

    Hematologic Malignancies Division
    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Boston, MA 02215

    Lymphoma second opinions at satellite centers

    Dana-Farber/New Hampshire Oncology-Hematology

  •   Email
  •   Print
  •   Share
  • Make an Appointment

    • New adult lymphoma patients:
      617-632-6246 or 617-632-5138
    • Make Appointment Online
  • Highest ranked in New England

  • How Our Blood Cancer Patients Rate Dana-Farber

  • Online Resource for Precision Cancer Medicine

    • Clinicians at Dana-Farber/
      Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine for certain types of blood cancers and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
  • Advances in Hematologic Malignancies eNewsletter

    • Advances in Hematologic Malignancies eNewsletter screenshotRead about advances in hematologic malignancies in our biannual eNewsletter for clinicians nationwide.
  • New Therapies and Research for Lymphoma

    • Ann LaCasce, MD, medical oncologist in the Dana-Farber/Brigham and Women's Cancer Center Adult Lymphoma Program, answers patients' questions about current and future therapies for lymphoma, including new research, genetics, and symptom management.
  • Learn About Lymphoma